A team from Roswell Park Comprehensive Cancer Center has identified the beta-adrenergic receptor (β-AR) as a driver of immune suppression and cancer growth in response to chronic stress, opening the possibility of targeting this receptor in cancer therapy and prevention.
University of Utah study finds risk of age-related diseases may be higher in younger B-NHL survivors
University of Utah researchers found that younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative risk of developing age-related diseases than older B-NHL survivors five years or more after cancer diagnosis.
The American Lung Association’s LUNG FORCE initiative released the 2021 Lung Health Barometer, a national survey that examines awareness, attitudes, and beliefs about lung health and lung cancer. This is the sixth year the survey has been conducted.
Researchers at Johns Hopkins Medicine and Italy’s Catholic University of the Sacred Heart medical school have shown that copper ions combined with disulfiram (DSF), a drug used for nearly 70 years as a treatment for alcoholism, may help kill and prevent the growth of medulloblastoma cancer cells in children.
The Association of Community Cancer Centers has conducted a national multi-phase effort to provide guidance on key issues related to the optimization of care for patients diagnosed with stages III and IV NSCLC.
The National Comprehensive Cancer Network published new NCCN Guidelines for Cervical Cancer: Poland Edition.
MD Anderson Cancer Center researchers reported that radiation therapy as monotherapy is a safe and effective noninvasive treatment for oligometastatic renal cell carcinoma.
People with liver cancer awaiting transplantation could benefit from non-invasive radiation treatments but are rarely given this therapy, according to a new analysis of U.S. national data.
Using fewer—but higher—doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a multi-institutional clinical trial showed.
The Accountability for Cancer Care through Undoing Racism and Equity (ACCURE) clinical trial—a prospective study designed to reduce gaps in cancer treatment completion and survival among Black and white patient populations— found that identifying and addressing obstacles that kept patients from finishing radiation treatments improved five-year survival rates for all patients and erased the survival gap between Black and white patients.
